194 related articles for article (PubMed ID: 26304236)
21. Anaphase catastrophe is a target for cancer therapy.
Galimberti F; Thompson SL; Ravi S; Compton DA; Dmitrovsky E
Clin Cancer Res; 2011 Mar; 17(6):1218-22. PubMed ID: 21288923
[TBL] [Abstract][Full Text] [Related]
22. NF-κB induces abnormal centrosome amplification by upregulation of CDK2 in laryngeal squamous cell cancer.
Liu JL; Ma HP; Lu XL; Sun SH; Guo X; Li FC
Int J Oncol; 2011 Oct; 39(4):915-24. PubMed ID: 21769424
[TBL] [Abstract][Full Text] [Related]
23. Induction of UGT1A1 and CYP2B6 by an antimitogenic factor in HepG2 cells is mediated through suppression of cyclin-dependent kinase 2 activity: cell cycle-dependent expression.
Sugatani J; Osabe M; Kurosawa M; Kitamura N; Ikari A; Miwa M
Drug Metab Dispos; 2010 Jan; 38(1):177-86. PubMed ID: 19797611
[TBL] [Abstract][Full Text] [Related]
24. The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.
Ferguson M; Luciani MG; Finlan L; Rankin EM; Ibbotson S; Fersht A; Hupp TR
Cell Cycle; 2004 Jan; 3(1):80-9. PubMed ID: 14657672
[TBL] [Abstract][Full Text] [Related]
25. CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels.
Gonçalves AB; Hasselbalch SK; Joensen BB; Patzke S; Martens P; Ohlsen SK; Quinodoz M; Nikopoulos K; Suleiman R; Damsø Jeppesen MP; Weiss C; Christensen ST; Rivolta C; Andersen JS; Farinelli P; Pedersen LB
Elife; 2021 Jul; 10():. PubMed ID: 34259627
[TBL] [Abstract][Full Text] [Related]
26. Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells.
Matsumoto Y; Hayashi K; Nishida E
Curr Biol; 1999 Apr; 9(8):429-32. PubMed ID: 10226033
[TBL] [Abstract][Full Text] [Related]
27. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
Calbó J; Serna C; Garriga J; Graña X; Mazo A
Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
[TBL] [Abstract][Full Text] [Related]
28. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
30. Preventing the degradation of mps1 at centrosomes is sufficient to cause centrosome reduplication in human cells.
Kasbek C; Yang CH; Yusof AM; Chapman HM; Winey M; Fisk HA
Mol Biol Cell; 2007 Nov; 18(11):4457-69. PubMed ID: 17804818
[TBL] [Abstract][Full Text] [Related]
31. Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E.
Cheng PH; Rao XM; McMasters KM; Zhou HS
PLoS One; 2013; 8(2):e57340. PubMed ID: 23437375
[TBL] [Abstract][Full Text] [Related]
32. Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells.
Carstens CP; Krämer A; Fahl WE
Exp Cell Res; 1996 Nov; 229(1):86-92. PubMed ID: 8940252
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells.
Leontovich AA; Salisbury JL; Veroux M; Tallarita T; Billadeau D; McCubrey J; Ingle J; Galanis E; D'Assoro AB
Oncol Rep; 2013 May; 29(5):1785-8. PubMed ID: 23446853
[TBL] [Abstract][Full Text] [Related]
34. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.
Hydbring P; Bahram F; Su Y; Tronnersjö S; Högstrand K; von der Lehr N; Sharifi HR; Lilischkis R; Hein N; Wu S; Vervoorts J; Henriksson M; Grandien A; Lüscher B; Larsson LG
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):58-63. PubMed ID: 19966300
[TBL] [Abstract][Full Text] [Related]
37. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
38. CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability.
Tsang WY; Spektor A; Luciano DJ; Indjeian VB; Chen Z; Salisbury JL; Sánchez I; Dynlacht BD
Mol Biol Cell; 2006 Aug; 17(8):3423-34. PubMed ID: 16760425
[TBL] [Abstract][Full Text] [Related]
39. Cep97 and CP110 suppress a cilia assembly program.
Spektor A; Tsang WY; Khoo D; Dynlacht BD
Cell; 2007 Aug; 130(4):678-90. PubMed ID: 17719545
[TBL] [Abstract][Full Text] [Related]
40. CP110 suppresses primary cilia formation through its interaction with CEP290, a protein deficient in human ciliary disease.
Tsang WY; Bossard C; Khanna H; Peränen J; Swaroop A; Malhotra V; Dynlacht BD
Dev Cell; 2008 Aug; 15(2):187-97. PubMed ID: 18694559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
